Replicel Life Sciences Inc V.RP

Alternate Symbol(s): REPCF

Technology Scientific & Technical Instruments

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.

TSXV:RP - Post by User

Replicel Life Sciences Inc > The Countdown Begins

<< Previous

Bullboard Posts

Next >>

Comment by Genie29jon Aug 03, 2023 7:26pm

119 Views

Post# 35572327

RE:RE:RE:RE:The Countdown Begins

My largest purchase was at about 60¢, which at the time I thought was a massive bargain... little did I know! Ha

I still have faith in Andrew. Like I've said before, if there's one person on this planet more than anyone, it's him. Im sure it's a waiting game for him too.

I'd this ship sinks, I think the blood is on Lee's hands. I question if this Shiseido deal was the right move from the start..

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages